beta adrenergic antagonist-treated mesenchymal stem cell therapy (University of California Davis)

N/A

Report date: 2025/03/14 16:23:37

Base Information

Drug Namebeta adrenergic antagonist-treated mesenchymal stem cell therapy (University of California Davis)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of California Davis
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A